This approval adds to Granules India's existing 67 ANDA approvals from the US FDA, strengthening its position in regulated ...

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

Exclusive: One in three researchers say their peers force them to carry out tests with animals if their work is to be ...

Clinical stage biopharma Kezar Life Sciences is discontinuing its lupus nephritis (LN) clinical programme following the death ...

This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.

重穿这套外套 和三哥请大家喝茶 重穿这套外套 和三哥请大家喝茶 ...

Bupropion hydrochloride extended-release tablets are widely prescribed for the treatment of major depressive disorder and for ...

Interim phase 3 results showed the IL-13 monoclonal antibody improves histology and symptoms in EoE, even in participants ...

The medication is widely prescribed for the treatment of major depressive disorder and for the prevention of seasonal ...

Granules India's US subsidiary receives FDA approval for generic Bupropion Hydrochloride Extended-Release Tablets, expanding ...

Watsons, the leading health, wellness, and beauty retailer in the Philippines, recently held an engaging vaccination ...

Granules Pharmaceuticals, Inc., a 100% foreign subsidiary of Granules India received the U.S. Food & Drug Administration (USFDA) approval for abbreviated new drug application (ANDA) of Bupropion ...